Combination therapy in angina: A review of combined haemodynamic and treatment and the role for combined haemodynamic and cardiac metabolic agents

International Journal of Clinical Practice

Volumn 55, Issue 4, 2001, Pages 256-261

  Jackson, G ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CARNITINE; DILTIAZEM; FELODIPINE; ISOSORBIDE DINITRATE; METOPROLOL; NIFEDIPINE; NISOLDIPINE; NITRATE; PLACEBO; PROPRANOLOL; TRIMETAZIDINE;

ANGINA PECTORIS; CARDIOLOGY; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART PERFORMANCE; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL SOCIETY; MONOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; ANGINA PECTORIS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HUMANS; NITRATES; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 0034981428     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology
2. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization
3. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial
4. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and total ischaemic burden in 608 patients with stable angina
5. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study
6. Characteristics of a contemporary population with angina pectoris
7. Fatty acid and glucose metabolism: A target for intervention
8. Meta-analysis of trials comparing β-blockers, calcium antagonists, and nitrates for stable angina
9. Pharmacological treatment of ischaemic heart disease: Monotherapy vs combination therapy
10. Combination of nitrates with other antianginal drugs
11. Combined beta-adrenergic and calcium-entry blockade in angina pectoris
12. Addition of felodipine to metoprolol vs replacement of metoprolol by felodipine in patients with angina pectoris despite adequate beta-blockade
13. Drug therapy: Nitrate therapy for stable angina pectoris
14. Potassium channel openers: Clinical applications in ischaemic heart disease: Overview of clinical efficacy of nicorandil
15. Attenuation of anti-ischaemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris
16. Value of the addition of amlodipine to atenolol in patients with angina pectoris despite adequate beta blockade
17. Optimal control of myocardial ischaemia: The benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina
18. Amlodipine versus diltiazem as additional antianginal treatment to atenolol
19. Effectiveness of nifedipine GITS in combination with atenolol in chronic stable angina
20. Effects of amlodipine on transient myocardial ischaemia in patients with a severe coronary condition treated with a beta-blocker
21. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina
22. A comparison of nisoldipine and nifedipine, in combination with atenolol, in the management of myocardial ischaemia
23. Atenolol or nicardipine alone is as efficacious in stable angina as their combination: A double-blind randomised trial
24. Bisdoprolol alone and in combination with amlodipine or nifedipine in the treatment of chronic stable angina
25. A comparative study of the effects of diltiazem, nifedipine and their association in stable effort angina
26. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina
27. 'Maximal' drug therapy is not necessarily optimal in chronic angina pectoris
28. Amlodipine in patients with stable angina pectoris treated with beta-blockers
29. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions
30. Glucose metabolism in the ischemic heart
31. Clinical benefits of a metabolic approach to the management of coronary patients
32. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
33. Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina
34. Combination treatment of trimetazidine and diltiazem in stable angina pectoris
35. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease
36. Efficacy and tolerance of trimetazidine in combination with a conventional antianginal drug in patients with stable effort angina
37. Trimetazidine: A review of its use in stable angina pectoris and other coronary conditions